Home

Hindustan Bio Sciences Ltd PE Ratio

Image

Hindustan Bio Sciences Ltd

NSE: HINDBIOSCIENCE

PE

283.3

Last updated on: Feb 11, 2025

Key Highlights

  • The P/E Ratio of Hindustan Bio Sciences Ltd is 283.3 as of 11 Feb 15:30 PM .
  • The P/E Ratio of Hindustan Bio Sciences Ltd changed from 18 on March 2020 to 120.8 on March 2024 . This represents a CAGR of 46.34% over 5 years.
  • The Latest Trading Price of Hindustan Bio Sciences Ltd is ₹ 8.5 as of 11 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Hindustan Bio Sciences Ltd

No data available

Company Fundamentals for Hindustan Bio Sciences Ltd

Image

Hindustan Bio Sciences Ltd

NSE: HINDBIOSCIENCE

Share Price

₹ 8.5

-0.20 (-2.30%)

stock direction

Last updated on: Feb 11, 2025

Market Price of Hindustan Bio Sciences Ltd

1M

1Y

3Y

5Y

Monitoring Hindustan Bio Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Feb 20258.5
10 Feb 20258.7
07 Feb 20259.55
06 Feb 20258.74
05 Feb 20258.34
04 Feb 20258.74
03 Feb 20258.73
01 Feb 20259.17
31 Jan 20259.49
30 Jan 20259.4

SWOT Analysis Of Hindustan Bio Sciences Ltd

Strength

1

che

Weakness

0

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Hindustan Bio Sciences Ltd

Asset Value vs Market Value of Hindustan Bio Sciences Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Hindustan Bio Sciences Ltd8.71
Sun Pharmaceuticals Industries Ltd407827
Divis Laboratories Ltd157931
Cipla Ltd117322
Torrent Pharmaceuticals Ltd105081
Mankind Pharma Ltd101135

PE Ratio of Hindustan Bio Sciences Ltd Explained

8.71

Market cap

0

Earnings

283.3X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Hindustan Bio Sciences Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Hindustan Bio Sciences Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Hindustan Bio Sciences Ltd

No data available

* All values are in %

About Hindustan Bio Sciences Ltd

  • Hindustan Bio Science Ltd (Formerly known Hindustan Softel Ltd) was incorporated as Public Limited Company on December 16, 1991.
  • The Company engaged in the manufacturing and sale of pharmaceutical products is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors.
  • The Company initially commenced operations in 1992 by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates. Previously, it was engaged in cement manufacturing and due to sluggish in the industry the company diversified its business into Bio Technology & Pharmaceuticals activities and the name of the Company was changed from Garuda Cements to Hindustan Bio-Sciences Ltd. In 2001, it diversified into software field and subsequently changed its name to Hindustan Softel Limited which presently got changed into Hindustan Bio Sciences Ltd.

Hindustan Bio Sciences Ltd News Hub

Hindustan Bio Sciences to hold AGM

Hindustan Bio Sciences announced that the 32nd Annual General Meeting (AGM) of the company will be h

Read more

02 Aug 24

Hindustan Bio Sciences schedules AGM

Hindustan Bio Sciences announced that the 32th Annual General Meeting (AGM) of the company will be h

Read more

02 Aug 24

Hindustan Bio Sciences reports standalone net profit of Rs 0.08 crore in the June 2024 quarter

Net profit of Hindustan Bio Sciences reported to Rs 0.08 crore in the quarter ended June 2024 as aga

Read more

01 Aug 24

Hindustan Bio Sciences to table results

Hindustan Bio Sciences will hold a meeting of the Board of Directors of the Company on 30 October 20

Read more

17 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Hindustan Bio Sciences Ltd

What is the current PE Ratio of Hindustan Bio Sciences Ltd?

The Current PE Ratio of Hindustan Bio Sciences Ltd is 283.33 as on 11 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 11 Feb 2025.

What was the PE Ratio of Hindustan Bio Sciences Ltd last year?

The PE Ratio of Hindustan Bio Sciences Ltd was 0.0 last year, now the PE ratio is 283.33, showing a year-on-year growth of -%.

What does the PE Ratio of Hindustan Bio Sciences Ltd indicate about its stock?

The PE Ratio of Hindustan Bio Sciences Ltd is 283.33. This ratio indicates that investors are willing to pay 283.33 times the earnings per share for each share of Hindustan Bio Sciences Ltd.

What is the PE Ratio Growth of Hindustan Bio Sciences Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Hindustan Bio Sciences Ltd grew by -% whereas, the EPS ratio grew by -20.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions